Startups
2005
ARCHIVEL FARMA SLA R&D biotech company that develops immunotherapeutic agents to respond to unmet medical needs, notably in multidrug-resistant tuberculosis (MDR-TB) but also asthma, allergic rhinitis and some types of cancer.
Participation sold in 2012
Participation sold in 2012
Address
Carrer de Fogars de Tordera 61, 08916 Badalona, Spain
Finance Data
CERCA ownership
Badalona, Spain
1995
IGTP
Status & Deeptech areas
Company Status & Company Deeptech AreasCurrent company status
DeepTech Area
Spinoff information
Company Description
Archivel Farma works in the discovering and development of new biopharmaceutical agents to prevent and treat tuberculosis and other diseases susceptible to immunomodulatory intervention
Archivel Farma have designed a new strategy to help patients suffering from MDR-TB and rifampicin-resistant TB (RR-TB) to overcome the disease. We are developing RUTI® as adjunctive therapy to antibiotic treatment that will help to reduce the time of medication and the relapse rates by increasing efficacy of chemotherapy treatment.
Archivel Farma have designed a new strategy to help patients suffering from MDR-TB and rifampicin-resistant TB (RR-TB) to overcome the disease. We are developing RUTI® as adjunctive therapy to antibiotic treatment that will help to reduce the time of medication and the relapse rates by increasing efficacy of chemotherapy treatment.
Company Closed or Exit Year